Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc. Aug 12, 2024 04:22PM
Citius Pharmaceuticals (CTXR) Announces TenX Keane Shareholder Approval of Merger with Citius Oncology Aug 5, 2024 08:02AM
Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc. Aug 5, 2024 08:00AM
Citius Pharmaceuticals (CTXR) Details Near-Term Milestones for Late-Stage Candidates Jul 10, 2024 09:10AM
Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates Jul 10, 2024 09:10AM


May 14, 2024 04:05PM Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update
Feb 14, 2024 04:30PM Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business Update
Jan 2, 2024 08:30AM Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update
Oct 24, 2023 07:31AM Citius Pharmaceuticals (CTXR) to Merge Wholly Owned Subsidiary with TenX Keane Acquisition (TENK) to Form Publicly Listed Citius Oncology, Inc.
Oct 24, 2023 07:30AM Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.